Fukudo, Masahide <br/><br/>
Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients.  [electronic resource] 

 -  Pharmacogenetics and genomics  May 2008 
 - 413-23 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1744-6872 
<br/><br/><label>Standard No.: </label>10.1097/FPC.0b013e3282f9ac01  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ATP Binding Cassette Transporter, Subfamily B<br/>ATP Binding Cassette Transporter, Subfamily B, Member 1--genetics<br/>Administration, Oral<br/>Adult<br/>Aged<br/>Cytochrome P-450 CYP3A--genetics<br/>Drug Resistance--genetics<br/>Enterocytes--metabolism<br/>Female<br/>Genotype<br/>Graft Rejection--genetics<br/>Humans<br/>Immunosuppressive Agents--administration & dosage<br/>Kidney--metabolism<br/>Liver Transplantation--physiology<br/>Living Donors<br/>Male<br/>Metabolic Clearance Rate<br/>Middle Aged<br/>Pharmacogenetics<br/>Renal Insufficiency--chemically induced<br/>Tacrolimus--administration & dosage